Antisense-mediated reduction of proprotein convertase subtilisin/kexin type 9 (PCSK9): a first-in-human randomized, placebo-controlled trial

作者:van Poelgeest Eveline P; Hodges Michael R; Moerland Matthijs; Tessier Yann; Levin Arthur A; Persson Robert; Lindholm Marie W; Erichsen Kamille Dumong; Orum Henrik; Cohen Adam F; Burggraaf Jacobus
来源:British Journal of Clinical Pharmacology, 2015, 80(6): 1350-1361.
DOI:10.1111/bcp.12738